Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chittenden

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Biology|July 1, 1993
Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2FT Chittenden, D M Livingston, J A DeCaprio
Cell|June 24, 1991
The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding proteinT Chittenden, D M Livingston, W G Kaelin
Molecular and Cellular Biology|December 14, 1999
ei24, a p53 response gene involved in growth suppression and apoptosisZ Gu, C Flemington, T Chittenden, et al.
Journal of Pharmaceutical Sciences|February 1, 2014
Development of a mixed-effect pharmacokinetic model for vehicle modulated in vitro transdermal flux of topically applied penetrantsJason T Chittenden, James D Brooks, Jim E Riviere
British Journal of Cancer|August 1, 1993
Structural and functional contributions to the G1 blocking action of the retinoblastoma protein. (the 1992 Gordon Hamilton Fairley Memorial Lecture)D M Livingston, W Kaelin, T Chittenden, et al.
Genes & Development|June 11, 1992
Identification of a growth suppression domain within the retinoblastoma gene productX Q Qin, T Chittenden, D M Livingston, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 14, 2022
Pharmacokinetic/pharmacodynamic modeling of ketoprofen and flunixin at piglet castration and tail-dockingEmma Nixon, Jason T Chittenden, Ronald E Baynes, et al.
The Journal of Biological Chemistry|June 6, 2000
Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155X M Zhou, Y Liu, G Payne, et al.
Journal of Applied Toxicology : JAT|September 6, 2016
Pharmacokinetics of <sup>14</sup> C-ortho-phenylphenol following intravenous administration in pigsEmma Nixon, James D Brooks, Patricia A Routh, et al.
Cell|January 10, 1992
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated mannerS Shirodkar, M Ewen, J A DeCaprio, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Biology|July 1, 1993
Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2FT Chittenden, D M Livingston, J A DeCaprio
Cell|June 24, 1991
The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding proteinT Chittenden, D M Livingston, W G Kaelin
Molecular and Cellular Biology|December 14, 1999
ei24, a p53 response gene involved in growth suppression and apoptosisZ Gu, C Flemington, T Chittenden, et al.
Journal of Pharmaceutical Sciences|February 1, 2014
Development of a mixed-effect pharmacokinetic model for vehicle modulated in vitro transdermal flux of topically applied penetrantsJason T Chittenden, James D Brooks, Jim E Riviere
British Journal of Cancer|August 1, 1993
Structural and functional contributions to the G1 blocking action of the retinoblastoma protein. (the 1992 Gordon Hamilton Fairley Memorial Lecture)D M Livingston, W Kaelin, T Chittenden, et al.
Genes & Development|June 11, 1992
Identification of a growth suppression domain within the retinoblastoma gene productX Q Qin, T Chittenden, D M Livingston, et al.
Journal of Veterinary Pharmacology and Therapeutics|July 14, 2022
Pharmacokinetic/pharmacodynamic modeling of ketoprofen and flunixin at piglet castration and tail-dockingEmma Nixon, Jason T Chittenden, Ronald E Baynes, et al.
The Journal of Biological Chemistry|June 6, 2000
Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155X M Zhou, Y Liu, G Payne, et al.
Journal of Applied Toxicology : JAT|September 6, 2016
Pharmacokinetics of <sup>14</sup> C-ortho-phenylphenol following intravenous administration in pigsEmma Nixon, James D Brooks, Patricia A Routh, et al.
Cell|January 10, 1992
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated mannerS Shirodkar, M Ewen, J A DeCaprio, et al.
Pageof 4